We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$199M
AUM Growth
-$34.6B
Cap. Flow
-$35.1B
Cap. Flow %
-17,587.21%
Top 10 Hldgs %
62.92%
Holding
1,077
New
Increased
3
Reduced
57
Closed
1,016

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.49B
2
MSFT icon
Microsoft
MSFT
+$2.09B
3
AAPL icon
Apple
AAPL
+$1.44B
4
AMZN icon
Amazon
AMZN
+$1.36B
5
META icon
Meta Platforms (Facebook)
META
+$721M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Consumer Discretionary 12.36%
3 Financials 10.02%
4 Communication Services 9%
5 Healthcare 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRZ
1076
Amrize Ltd
AMRZ
$27.3B
-21,486
Closed -$1.06M
RAL
1077
Ralliant Corp
RAL
$7.49B
-5,327
Closed -$258K

Similar funds

Axa's Q3 2025 Portfolio in Review

As of Q3 2025, Axa held 1,077 positions worth $199M, down 99% from $34.8B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Axa withdrew a net $35.1B in Q3 2025, closing 1,016 positions and reducing 57 holdings. Its most notable exit was Broadcom, an estimated $666M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Axa added an estimated $6.03M to iShares Core MSCI Emerging Markets ETF.

  • Axa added most to iShares Core MSCI Emerging Markets ETF in Q3 2025, an estimated $6.03M increase.
  • Axa's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.49B.
  • Axa fully exited Broadcom in Q3 2025, selling an estimated $666M.
  • Axa's ten largest holdings make up 63% of its $199M portfolio in Q3 2025.
  • Axa opened 0 new positions and closed 1,016 in Q3 2025.
  • Axa's portfolio value fell 99% quarter-over-quarter to $199M.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.